Deleted Journal,
Journal Year:
2024,
Volume and Issue:
unknown
Published: April 2, 2024
Brain
tumors
are
a
threat
to
life
for
every
other
human
being,
be
it
adults
or
children.
Gliomas
one
of
the
deadliest
brain
with
an
extremely
difficult
diagnosis.
The
reason
is
their
complex
and
heterogenous
structure
which
gives
rise
subjective
as
well
objective
errors.
Their
manual
segmentation
laborious
task
due
irregular
appearance.
To
cater
all
these
issues,
lot
research
has
been
done
going
on
develop
AI-based
solutions
that
can
help
doctors
radiologists
in
effective
diagnosis
gliomas
least
errors,
but
end-to-end
system
still
missing.
An
all-in-one
framework
proposed
this
research.
developed
multi-task
learning
(MTL)
architecture
feature
attention
module
classify,
segment,
predict
overall
survival
by
leveraging
relationships
between
similar
tasks.
Uncertainty
estimation
also
incorporated
into
enhance
confidence
level
healthcare
practitioners.
Extensive
experimentation
was
performed
using
combinations
MRI
sequences.
tumor
(BraTS)
challenge
datasets
2019
2020
were
used
experimental
purposes.
Results
best
model
four
sequences
show
95.1%
accuracy
classification,
86.3%
dice
score
segmentation,
mean
absolute
error
(MAE)
456.59
prediction
test
data.
It
evident
from
results
deep
learning–based
MTL
models
have
potential
automate
whole
analysis
process
give
efficient
inference
time
without
intervention.
quantification
confirms
idea
more
data
improve
generalization
ability
turn
produce
accurate
less
uncertainty.
utilized
clinical
setup
initial
screening
glioma
patients.
Cureus,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Oct. 29, 2024
Artificial
intelligence
(AI)
is
rapidly
transforming
the
field
of
radiology,
offering
significant
advancements
in
diagnostic
accuracy,
workflow
efficiency,
and
patient
care.
This
article
explores
AI's
impact
on
various
subfields
emphasizing
its
potential
to
improve
clinical
practices
enhance
outcomes.
AI-driven
technologies
such
as
machine
learning,
deep
natural
language
processing
(NLP)
are
playing
a
pivotal
role
automating
routine
tasks,
aiding
early
disease
detection,
supporting
decision-making,
allowing
radiologists
focus
more
complex
challenges.
Key
applications
AI
radiology
include
improving
image
analysis
through
computer-aided
diagnosis
(CAD)
systems,
which
detection
abnormalities
imaging,
tumors.
tools
have
demonstrated
high
accuracy
analyzing
medical
images,
integrating
data
from
multiple
imaging
modalities
CT,
MRI,
PET
provide
comprehensive
insights.
These
facilitate
personalized
treatment
planning
complement
radiologists'
workflows.
However,
for
be
fully
integrated
into
workflows,
several
challenges
must
addressed,
including
ensuring
transparency
how
algorithms
work,
protecting
data,
avoiding
biases
that
could
affect
diverse
populations.
Developing
explainable
systems
can
clearly
show
decisions
made
crucial,
seamlessly
fit
existing
systems.
Collaboration
between
radiologists,
developers,
policymakers,
alongside
strong
ethical
guidelines
regulatory
oversight,
will
key
implemented
safely
effectively
practice.
Overall,
holds
tremendous
promise
revolutionizing
radiology.
Through
ability
automate
capabilities,
streamline
has
significantly
quality
efficiency
practices.
Continued
research,
development,
collaboration
crucial
unlocking
full
addressing
accompany
adoption.
Cancers,
Journal Year:
2024,
Volume and Issue:
16(2), P. 300 - 300
Published: Jan. 10, 2024
Machine
Learning
is
entering
a
phase
of
maturity,
but
its
medical
applications
still
lag
behind
in
terms
practical
use.
The
field
oncological
radiology
(and
neuro-oncology
particular)
at
the
forefront
these
developments,
now
boosted
by
success
Deep-Learning
methods
for
analysis
images.
This
paper
reviews
detail
some
most
recent
advances
use
Deep
this
field,
from
broader
topic
development
Machine-Learning-based
analytical
pipelines
to
specific
instantiations
neuro-oncology;
latter
including
groundbreaking
ultra-low
magnetic
resonance
imaging.
The Egyptian Journal of Radiology and Nuclear Medicine,
Journal Year:
2025,
Volume and Issue:
56(1)
Published: March 17, 2025
Abstract
Background
Brain
cancer
is
a
global
health
concern,
with
significant
morbidity
and
mortality
worldwide.
Distinguishing
glioma
grades
vital
for
treatment,
yet
traditional
methods
like
brain
imaging
biopsy
have
their
own
limitations.
This
study
aimed
to
develop
optimized
classification
predictive
models
distinguish
grade
II
from
III
gliomas
using
statistical
machine
learning
combined
radiomic
imaging.
Methods
A
total
of
135
MRI
series
tumors
(68
67
III)
were
obtained
two
distinct
public
datasets.
Every
tumor
underwent
manual
segmentation,
preprocessing,
cropping.
large
number
wavelet-based,
first-order,
textural,
shape
characteristics
then
computed.
Principal
component
analysis
was
used
dimensionality
reduction.
Two
feature
selectors,
namely
K-best
percentile
employed.
Twelve
different
supervised
algorithms
applied.
selectors
along
hyperparameter
optimization
conducted.
Results
The
top
three
performing
linear
discriminant
(LDA),
support
vector
machine,
logistic
regression.
LDA
the
highest
surpassing
all
other
both
selectors.
Using
selector,
attained
an
area
under
receiver
characteristic
curve
(AUROC)
0.96,
accuracy
0.91,
sensitivity
0.95,
specificity
0.86.
With
it
maintained
strong
performance
AUROC
0.92,
0.89.
Conclusions
Statistical
approaches
significantly
high
discriminative
power.
interestingly
outperformed
others
in
accuracy,
AUC,
sensitivity,
highlighting
advanced
capabilities
versus
gliomas.
CytoJournal,
Journal Year:
2025,
Volume and Issue:
22, P. 45 - 45
Published: April 19, 2025
The
application
of
artificial
intelligence
(AI)
in
cancer
pathology
has
shown
significant
potential
to
enhance
diagnostic
accuracy,
streamline
workflows,
and
support
precision
oncology.
This
review
examines
the
current
applications
AI
across
various
types,
including
breast,
lung,
prostate,
colorectal
cancer,
where
aids
tissue
classification,
mutation
detection,
prognostic
predictions.
key
technologies
driving
these
advancements
include
machine
learning,
deep
computer
vision,
which
enable
automated
analysis
histopathological
images
multi-modal
data
integration.
Despite
promising
developments,
challenges
persist,
ensuring
privacy,
improving
model
interpretability,
meeting
regulatory
standards.
Furthermore,
this
explores
future
directions
AI-driven
pathology,
real-time
diagnostics,
explainable
AI,
global
accessibility,
emphasizing
importance
collaboration
between
pathologists.
Addressing
leveraging
AI’s
full
could
lead
a
more
efficient,
equitable,
personalized
approach
care.
Advances in computational intelligence and robotics book series,
Journal Year:
2025,
Volume and Issue:
unknown, P. 295 - 310
Published: Feb. 28, 2025
AI
has
changed
the
way
new
radiopharmaceuticals
are
being
developed,
improved
pharmacodynamics
in
precision
medicine
and
made
drug
discovery
more
efficient.
Radiopharmaceuticals
play
an
important
role
both
diagnostic
imaging
as
well
targeted
therapy;
however
conventional
development
process
is
complex
lengthy.
Here
does
speed
up
through
machine
learning
deep
techniques,
targets
can
be
identified
a
shorter
time,
along
with
molecular
designing
of
better
radiolabeling
methodology.
These
enhancements
occur
biomarker
identification,
selectivity,
pharmacokinetics.
In
sciences,
refines
outlook
definition,
intensifies
image
reconstruction,
optimizes
dosing
according
to
patient's
characteristics.
It
also
simplifies
clinical
trials
pushing
predictive
analysis
patient
categorization.
With
help
AI,
will
completely
change
concept
healthcare,
strengthen
quality
results
obtained,
create
opportunities
for
global
precise
medicine.
Cancers,
Journal Year:
2025,
Volume and Issue:
17(9), P. 1510 - 1510
Published: April 30, 2025
Artificial
intelligence
(AI)
is
revolutionizing
cancer
imaging,
enhancing
screening,
diagnosis,
and
treatment
options
for
clinicians.
AI-driven
applications,
particularly
deep
learning
machine
learning,
excel
in
risk
assessment,
tumor
detection,
classification,
predictive
prognosis.
Machine
algorithms,
especially
frameworks,
improve
lesion
characterization
automated
segmentation,
leading
to
enhanced
radiomic
feature
extraction
delineation.
Radiomics,
which
quantifies
imaging
features,
offers
personalized
response
predictions
across
various
modalities.
AI
models
also
facilitate
technological
improvements
non-diagnostic
tasks,
such
as
image
optimization
medical
reporting.
Despite
advancements,
challenges
persist
integrating
into
healthcare,
tracking
accurate
data,
ensuring
patient
privacy.
Validation
through
clinician
input
multi-institutional
studies
essential
safety
model
generalizability.
This
requires
support
from
radiologists
worldwide
consideration
of
complex
regulatory
processes.
Future
directions
include
elaborating
on
existing
optimizations,
advanced
techniques,
improving
patient-centric
medicine,
expanding
healthcare
accessibility.
can
enhance
optimizing
precision
medicine
outcomes.
Ongoing
multidisciplinary
collaboration
between
radiologists,
oncologists,
software
developers,
bodies
crucial
AI's
growing
role
clinical
oncology.
review
aims
provide
an
overview
the
applications
oncologic
while
discussing
their
limitations.